Immediate Impact
1 by Nobel laureates 1 from Science/Nature 78 standout
Citing Papers
Targeting KRAS: from metabolic regulation to cancer treatment
2025 Standout
Lorlatinib Versus Crizotinib in Patients With Advanced ALK -Positive Non–Small Cell Lung Cancer: 5-Year Outcomes From the Phase III CROWN Study
2024 Standout
Works of Alexandra Langlais being referenced
EGFR tyrosine kinase inhibitorsversuschemotherapy inEGFRwild-type pre-treated advanced nonsmall cell lung cancer in daily practice
2017
Weekly paclitaxel plus bevacizumab versus docetaxel as second or third-line treatment in advanced non-squamous non-small cell lung cancer (NSCLC): Results from the phase III study IFCT-1103 ULTIMATE.
2016
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Alexandra Langlais | 364 | 347 | 87 | 94 | 55 | 510 | |
| Yuichi Tambo | 361 | 305 | 63 | 99 | 41 | 460 | |
| Masashi Mikubo | 237 | 197 | 92 | 112 | 39 | 419 | |
| Vincenzo Di Lauro | 195 | 203 | 137 | 152 | 27 | 456 | |
| Ester Del Signore | 292 | 390 | 62 | 106 | 43 | 539 | |
| Zhiyong Ma | 279 | 247 | 66 | 177 | 59 | 503 | |
| N. Vardakis | 199 | 343 | 112 | 67 | 35 | 430 | |
| Vega Iranzo | 191 | 280 | 108 | 104 | 43 | 437 | |
| Zhiyu Huang | 367 | 421 | 61 | 104 | 47 | 567 | |
| Tianqing Chu | 268 | 306 | 159 | 216 | 45 | 571 | |
| Giorgia Guaitoli | 160 | 223 | 117 | 140 | 27 | 420 |
All Works
Login with ORCID to disown or claim papers
Loading papers...